{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T08:07:41Z","timestamp":1791878861763,"version":"4.3.4"},"reference-count":134,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:00:00Z","timestamp":1760400000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vascular Pharmacology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.vph.2025.107553","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T15:37:57Z","timestamp":1760542677000},"page":"107553","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Hypothalamic regulation of obesity: Revealing the therapeutic potential of a novel anti-obesity peptide"],"prefix":"10.1016","volume":"161","author":[{"given":"Yi Ning","family":"Choo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ram","family":"Narayanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vetriselvan","family":"Subramaniyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vph.2025.107553_bb0005","doi-asserted-by":"crossref","first-page":"3611","DOI":"10.2147\/DMSO.S275898","article-title":"Obesity, insulin resistance, and type 2 diabetes: associations and therapeutic implications","volume":"13","author":"Wondmkun","year":"2020","journal-title":"Diabetes Metab. Syndr. Obes."},{"issue":"5","key":"10.1016\/j.vph.2025.107553_bb0010","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/s41574-019-0176-8","article-title":"Obesity: global epidemiology and pathogenesis","volume":"15","author":"Bluher","year":"2019","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.vph.2025.107553_bib666","series-title":"Obesity and overweight: World Health Organization","year":"2025"},{"key":"10.1016\/j.vph.2025.107553_bb0015","doi-asserted-by":"crossref","DOI":"10.1177\/2042018820934955","article-title":"Adult obesity complications: challenges and clinical impact","volume":"11","author":"Ansari","year":"2020","journal-title":"Ther. Adv. Endocrinol. Metab."},{"issue":"20","key":"10.1016\/j.vph.2025.107553_bb0020","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1001\/jama.2023.19897","article-title":"Obesity management in adults: a review","volume":"330","author":"Elmaleh-Sachs","year":"2023","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.vph.2025.107553_bb0025","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1242\/dev.139055","article-title":"Development of the hypothalamus: conservation, modification and innovation","volume":"144","author":"Xie","year":"2017","journal-title":"Development"},{"issue":"4","key":"10.1016\/j.vph.2025.107553_bb0030","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/s12276-022-00741-z","article-title":"Hypothalamic control of energy expenditure and thermogenesis","volume":"54","author":"Tran","year":"2022","journal-title":"Exp. Mol. Med."},{"issue":"2","key":"10.1016\/j.vph.2025.107553_bb0035","doi-asserted-by":"crossref","first-page":"T25","DOI":"10.1530\/JOE-13-0398","article-title":"Hypothalamic and brainstem neuronal circuits controlling homeostatic energy balance","volume":"220","author":"Schneeberger","year":"2014","journal-title":"J. Endocrinol."},{"issue":"7","key":"10.1016\/j.vph.2025.107553_bb0040","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1038\/s12276-021-00644-5","article-title":"Hypothalamic primary cilium: A hub for metabolic homeostasis","volume":"53","author":"Yang","year":"2021","journal-title":"Exp. Mol. Med."},{"issue":"2","key":"10.1016\/j.vph.2025.107553_bb0045","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1210\/endrev\/bnab025","article-title":"Arcuate nucleus-dependent regulation of metabolism-pathways to obesity and diabetes mellitus","volume":"43","author":"Jais","year":"2022","journal-title":"Endocr. Rev."},{"issue":"4","key":"10.1016\/j.vph.2025.107553_bb0050","doi-asserted-by":"crossref","first-page":"229","DOI":"10.5483\/BMBRep.2015.48.4.272","article-title":"Network of hypothalamic neurons that control appetite","volume":"48","author":"Sohn","year":"2015","journal-title":"BMB Rep."},{"key":"10.1016\/j.vph.2025.107553_bb0055","first-page":"21","article-title":"Gene expression and the control of food intake by hypothalamic POMC\/CART Neurons","volume":"3","author":"Hill","year":"2010","journal-title":"Open Neuroendocrinol. J."},{"issue":"7","key":"10.1016\/j.vph.2025.107553_bb0060","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1089\/thy.2023.0173","article-title":"Regulation of thyroid hormone levels by hypothalamic thyrotropin-releasing hormone Neurons","volume":"33","author":"Costa","year":"2023","journal-title":"Thyroid"},{"issue":"8","key":"10.1016\/j.vph.2025.107553_bb0065","doi-asserted-by":"crossref","DOI":"10.1111\/obr.13763","article-title":"Corticotropin-releasing hormone and obesity: from fetal life to adulthood","volume":"25","author":"Vasconcelos","year":"2024","journal-title":"Obes. Rev."},{"issue":"10","key":"10.1016\/j.vph.2025.107553_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.113305","article-title":"High-calorie diets uncouple hypothalamic oxytocin neurons from a gut-to-brain satiation pathway via kappa-opioid signaling","volume":"42","author":"Gruber","year":"2023","journal-title":"Cell Rep."},{"issue":"2","key":"10.1016\/j.vph.2025.107553_bb0075","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1210\/endrev\/bnac015","article-title":"Brown adipose tissue-a translational perspective","volume":"44","author":"Carpentier","year":"2023","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.vph.2025.107553_bb0080","doi-asserted-by":"crossref","first-page":"830","DOI":"10.3389\/fendo.2019.00830","article-title":"Orexins\/Hypocretins: key regulators of energy homeostasis","volume":"10","author":"Milbank","year":"2019","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"1","key":"10.1016\/j.vph.2025.107553_bb0085","article-title":"Hypothalamic MCH Neurons: From feeding to cognitive control","volume":"5","author":"Concetti","year":"2024","journal-title":"Function (Oxf)"},{"issue":"3","key":"10.1016\/j.vph.2025.107553_bb0090","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1152\/jn.00359.2020","article-title":"Energy state alters regulation of proopiomelanocortin neurons by glutamatergic ventromedial hypothalamus neurons: pre- and postsynaptic mechanisms","volume":"125","author":"Rau","year":"2021","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.vph.2025.107553_bb0095","first-page":"634","article-title":"The inhibitory effects of Nesfatin-1 in ventromedial hypothalamus on gastric function and its regulation by nucleus Accumbens","volume":"7","author":"Gao","year":"2016","journal-title":"Front. Physiol."},{"issue":"Pt 2","key":"10.1016\/j.vph.2025.107553_bb0100","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1113\/jphysiol.2007.135590","article-title":"Hypothalamic leptin regulation of energy homeostasis and glucose metabolism","volume":"583","author":"Morton","year":"2007","journal-title":"J. Physiol."},{"issue":"9","key":"10.1016\/j.vph.2025.107553_bb0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0162352","article-title":"Steroidogenic factor 1 in the ventromedial nucleus of the hypothalamus regulates age-dependent obesity","volume":"11","author":"Kinyua","year":"2016","journal-title":"PloS One"},{"issue":"1","key":"10.1016\/j.vph.2025.107553_bb0110","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1210\/er.2018-00017","article-title":"Pathophysiology and individualized treatment of hypothalamic obesity following Craniopharyngioma and other Suprasellar tumors: a systematic Review","volume":"40","author":"van Iersel","year":"2019","journal-title":"Endocr. Rev."},{"issue":"6","key":"10.1016\/j.vph.2025.107553_bb0115","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S1471-4892(01)00110-2","article-title":"Hypothalamic peptides as drug targets for obesity","volume":"1","author":"Dhillo","year":"2001","journal-title":"Curr. Opin. Pharmacol."},{"issue":"6581","key":"10.1016\/j.vph.2025.107553_bb0120","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/381415a0","article-title":"Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y","volume":"381","author":"Erickson","year":"1996","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.vph.2025.107553_bb0125","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1111\/j.1365-2826.2008.01745.x","article-title":"Role of AMP-activated protein kinase in the control of appetite","volume":"20","author":"Kola","year":"2008","journal-title":"J. Neuroendocrinol."},{"issue":"5","key":"10.1016\/j.vph.2025.107553_bb0130","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s10571-011-9793-z","article-title":"NPY and stress 30 years later: the peripheral view","volume":"32","author":"Hirsch","year":"2012","journal-title":"Cell. Mol. Neurobiol."},{"issue":"11","key":"10.1016\/j.vph.2025.107553_bb0135","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1093\/jn\/130.11.2813","article-title":"Leptin rapidly inhibits hypothalamic neuropeptide Y secretion and stimulates corticotropin-releasing hormone secretion in adrenalectomized mice","volume":"130","author":"Jang","year":"2000","journal-title":"J. Nutr."},{"issue":"38","key":"10.1016\/j.vph.2025.107553_bb0140","doi-asserted-by":"crossref","first-page":"8657","DOI":"10.1523\/JNEUROSCI.2739-05.2005","article-title":"Insulin inhibits neuropeptide Y gene expression in the arcuate nucleus through GABAergic systems","volume":"25","author":"Sato","year":"2005","journal-title":"J. Neurosci."},{"issue":"1471","key":"10.1016\/j.vph.2025.107553_bb0145","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1098\/rstb.2006.1855","article-title":"Neuropeptide Y in normal eating and in genetic and dietary-induced obesity","volume":"361","author":"Beck","year":"2006","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"issue":"1","key":"10.1016\/j.vph.2025.107553_bb0150","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.pharmthera.2011.03.011","article-title":"The neuropeptide Y system: pathophysiological and therapeutic implications in obesity and cancer","volume":"131","author":"Zhang","year":"2011","journal-title":"Pharmacol. Ther."},{"issue":"3","key":"10.1016\/j.vph.2025.107553_bb0155","doi-asserted-by":"crossref","first-page":"R51","DOI":"10.1530\/JOE-20-0035","article-title":"PKA functions in metabolism and resistance to obesity: lessons from mouse and human studies","volume":"246","author":"London","year":"2020","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.vph.2025.107553_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2022.108113","article-title":"The regulation of PKA signaling in obesity and in the maintenance of metabolic health","volume":"237","author":"London","year":"2022","journal-title":"Pharmacol. Ther."},{"issue":"7","key":"10.1016\/j.vph.2025.107553_bb0165","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.2337\/db07-0857","article-title":"Hormone-sensitive lipase serine phosphorylation and glycerol exchange across skeletal muscle in lean and obese subjects: effect of beta-adrenergic stimulation","volume":"57","author":"Jocken","year":"2008","journal-title":"Diabetes"},{"issue":"6","key":"10.1016\/j.vph.2025.107553_bb0170","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.cmet.2011.10.009","article-title":"NPY and MC4R signaling regulate thyroid hormone levels during fasting through both central and peripheral pathways","volume":"14","author":"Vella","year":"2011","journal-title":"Cell Metab."},{"issue":"8032","key":"10.1016\/j.vph.2025.107553_bb0175","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/s41586-024-07863-6","article-title":"Sympathetic neuropeptide Y protects from obesity by sustaining thermogenic fat","volume":"634","author":"Zhu","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.vph.2025.107553_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2022.101455","article-title":"NPY derived from AGRP neurons controls feeding via Y1 and energy expenditure and food foraging behaviour via Y2 signalling","volume":"59","author":"Qi","year":"2022","journal-title":"Mol. Metab."},{"issue":"8","key":"10.1016\/j.vph.2025.107553_bb0185","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1111\/febs.16176","article-title":"AgRP neurons: regulators of feeding, energy expenditure, and behavior","volume":"289","author":"Deem","year":"2022","journal-title":"FEBS J."},{"key":"10.1016\/j.vph.2025.107553_bb0190","doi-asserted-by":"crossref","first-page":"515","DOI":"10.3389\/fendo.2019.00515","article-title":"Signal transduction and pathogenic modifications at the Melanocortin-4 receptor: a structural perspective","volume":"10","author":"Heyder","year":"2019","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"2","key":"10.1016\/j.vph.2025.107553_bb0195","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.cmet.2006.01.003","article-title":"AgRP in energy balance: will the real AgRP please stand up?","volume":"3","author":"Flier","year":"2006","journal-title":"Cell Metab."},{"key":"10.1016\/j.vph.2025.107553_bb0200","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.585887","article-title":"Leptin and obesity: role and clinical implication","volume":"12","author":"Obradovic","year":"2021","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"5","key":"10.1016\/j.vph.2025.107553_bb0205","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.cmet.2010.09.013","article-title":"Glucose stimulation of hypothalamic MCH neurons involves K(ATP) channels, is modulated by UCP2, and regulates peripheral glucose homeostasis","volume":"12","author":"Kong","year":"2010","journal-title":"Cell Metab."},{"issue":"13","key":"10.1016\/j.vph.2025.107553_bb0210","doi-asserted-by":"crossref","first-page":"7576","DOI":"10.1073\/pnas.131200698","article-title":"Identification and characterization of a melanin-concentrating hormone receptor","volume":"98","author":"An","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.vph.2025.107553_bb0215","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.cellsig.2015.01.008","article-title":"Identification of amino acids that are selectively involved in Gi\/o activation by rat melanin-concentrating hormone receptor 1","volume":"27","author":"Hamamoto","year":"2015","journal-title":"Cell Signal"},{"issue":"11","key":"10.1016\/j.vph.2025.107553_bb0220","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1038\/s41422-021-00569-8","article-title":"Structures of active melanocortin-4 receptor-Gs-protein complexes with NDP-alpha-MSH and setmelanotide","volume":"31","author":"Heyder","year":"2021","journal-title":"Cell Res."},{"key":"10.1016\/j.vph.2025.107553_bb0225","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1515\/med-2018-0040","article-title":"The melanin-concentrating hormone system in human, Rodent and Avian Brain","volume":"13","author":"Bencze","year":"2018","journal-title":"Open Med. (Wars)"},{"issue":"5","key":"10.1016\/j.vph.2025.107553_bb0230","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1085\/jgp.201210886","article-title":"Quantitative properties and receptor reserve of the IP(3) and calcium branch of G(q)-coupled receptor signaling","volume":"141","author":"Dickson","year":"2013","journal-title":"J. Gen. Physiol."},{"key":"10.1016\/j.vph.2025.107553_bb0235","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3389\/fnsys.2017.00032","article-title":"The melanin-concentrating hormone as an integrative peptide driving motivated behaviors","volume":"11","author":"Diniz","year":"2017","journal-title":"Front. Syst. Neurosci."},{"issue":"7","key":"10.1016\/j.vph.2025.107553_bb0240","doi-asserted-by":"crossref","first-page":"6725","DOI":"10.3390\/cimb46070401","article-title":"Examining the potential applicability of Orexigenic and Anorexigenic peptides in veterinary medicine for the Management of Obesity in companion animals","volume":"46","author":"Osiak-Wicha","year":"2024","journal-title":"Curr. Issues Mol. Biol."},{"issue":"4","key":"10.1016\/j.vph.2025.107553_bb0245","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqaa032","article-title":"Neurochemical characterization of brainstem pro-Opiomelanocortin cells","volume":"161","author":"Georgescu","year":"2020","journal-title":"Endocrinology"},{"key":"10.1016\/j.vph.2025.107553_bb0250","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2023.1238528","article-title":"Leptin signaling and its central role in energy homeostasis","volume":"17","author":"Liu","year":"2023","journal-title":"Front. Neurosci."},{"issue":"4","key":"10.1016\/j.vph.2025.107553_bb0255","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1172\/JCI24301","article-title":"PI3K integrates the action of insulin and leptin on hypothalamic neurons","volume":"115","author":"Xu","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.vph.2025.107553_bb0260","doi-asserted-by":"crossref","first-page":"214","DOI":"10.3389\/fnmol.2018.00214","article-title":"Endocannabinoid signaling at hypothalamic steroidogenic factor-1\/proopiomelanocortin synapses is sex- and diet-sensitive","volume":"11","author":"Fabelo","year":"2018","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.vph.2025.107553_bb0265","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3389\/fncel.2019.00205","article-title":"The role of ghrelin in regulating synaptic function and plasticity of feeding-associated circuits","volume":"13","author":"Serrenho","year":"2019","journal-title":"Front. Cell Neurosci."},{"issue":"12","key":"10.1016\/j.vph.2025.107553_bb0270","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1007\/s00109-010-0651-0","article-title":"Alpha-melanocyte stimulating hormone: production and degradation","volume":"88","author":"D\u2019Agostino","year":"2010","journal-title":"J. Mol. Med. (Berl)"},{"issue":"3","key":"10.1016\/j.vph.2025.107553_bb0275","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1042\/BJ20131115","article-title":"CREB phosphorylation at Ser133 regulates transcription via distinct mechanisms downstream of cAMP and MAPK signalling","volume":"458","author":"Naqvi","year":"2014","journal-title":"Biochem. J."},{"key":"10.1016\/j.vph.2025.107553_bb0280","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.981452","article-title":"Biochemical and physiological insights into TRH receptor-mediated signaling","volume":"10","author":"Trubacova","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"issue":"12","key":"10.1016\/j.vph.2025.107553_bb0285","doi-asserted-by":"crossref","first-page":"3217","DOI":"10.1113\/JP277193","article-title":"Alpha-melanocyte stimulating hormone increases the activity of melanocortin-3 receptor-expressing neurons in the ventral tegmental area","volume":"597","author":"West","year":"2019","journal-title":"J. Physiol."},{"issue":"9","key":"10.1016\/j.vph.2025.107553_bb0290","doi-asserted-by":"crossref","first-page":"e3699","DOI":"10.1210\/clinem\/dgac342","article-title":"Obesity and Hyperphagia with increased defective ACTH: a novel POMC variant","volume":"107","author":"van der Valk","year":"2022","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.vph.2025.107553_bb0295","first-page":"7","article-title":"Arcuate nucleus and lateral hypothalamic CART neurons in the mouse brain exert opposing effects on energy expenditure","author":"Farzi","year":"2018","journal-title":"Elife"},{"issue":"1","key":"10.1016\/j.vph.2025.107553_bb0300","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12986-021-00569-w","article-title":"STAT3 phosphorylation in central leptin resistance","volume":"18","author":"Liu","year":"2021","journal-title":"Nutr. Metab. (Lond.)"},{"issue":"10","key":"10.1016\/j.vph.2025.107553_bb0305","doi-asserted-by":"crossref","first-page":"4473","DOI":"10.1172\/JCI75276","article-title":"The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss","volume":"124","author":"Secher","year":"2014","journal-title":"J. Clin. Invest."},{"issue":"24","key":"10.1016\/j.vph.2025.107553_bb0310","doi-asserted-by":"crossref","first-page":"9224","DOI":"10.1523\/JNEUROSCI.20-24-09224.2000","volume":"20","author":"Fekete","year":"2000","journal-title":"J. Neurosci."},{"issue":"4","key":"10.1016\/j.vph.2025.107553_bb0315","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1053\/beem.2002.0230","article-title":"Hypothalamic regulation of energy homeostasis","volume":"16","author":"Sainsbury","year":"2002","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.vph.2025.107553_bb0320","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/j.2040-4603.2016.tb00694.x","article-title":"Regulation of the hypothalamic-pituitary-adrenocortical stress response","volume":"6","author":"Herman","year":"2016","journal-title":"Compr. Physiol."},{"issue":"4","key":"10.1016\/j.vph.2025.107553_bb0325","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1006\/brbi.1995.1026","article-title":"Regulation of the HPA axis by cytokines","volume":"9","author":"Turnbull","year":"1995","journal-title":"Brain Behav. Immun."},{"issue":"4","key":"10.1016\/j.vph.2025.107553_bb0330","doi-asserted-by":"crossref","first-page":"458","DOI":"10.2174\/1871530319666190206165626","article-title":"Metabolic association between leptin and the corticotropin releasing hormone","volume":"19","author":"Gioldasi","year":"2019","journal-title":"Endocr. Metab. Immune Disord. Drug Targets"},{"key":"10.1016\/j.vph.2025.107553_bb0335","article-title":"Glucocorticoids desensitize hypothalamic CRH neurons to norepinephrine and somatic stress activation via rapid nitrosylation-dependent regulation of alpha1 adrenoreceptor trafficking","author":"Weiss","year":"2024","journal-title":"bioRxiv"},{"issue":"2","key":"10.1016\/j.vph.2025.107553_bb0340","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1083\/jcb.201512075","article-title":"Different cAMP sources are critically involved in G protein-coupled receptor CRHR1 signaling","volume":"214","author":"Inda","year":"2016","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.vph.2025.107553_bb0345","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3389\/fendo.2020.00059","article-title":"Glucocorticoid metabolism in obesity and following weight loss","volume":"11","author":"Akalestou","year":"2020","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"4","key":"10.1016\/j.vph.2025.107553_bb0350","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1152\/physrev.00024.2017","article-title":"POMC: The physiological power of hormone processing","volume":"98","author":"Harno","year":"2018","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.vph.2025.107553_bb0355","doi-asserted-by":"crossref","first-page":"595","DOI":"10.3389\/fendo.2019.00595","article-title":"Identification of a novel functional Corticotropin-releasing hormone (CRH2) in chickens and its roles in stimulating pituitary TSHbeta expression and ACTH secretion","volume":"10","author":"Bu","year":"2019","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"1","key":"10.1016\/j.vph.2025.107553_bb0360","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1152\/physrev.00015.2003","article-title":"Brown adipose tissue: function and physiological significance","volume":"84","author":"Cannon","year":"2004","journal-title":"Physiol. Rev."},{"issue":"3","key":"10.1016\/j.vph.2025.107553_bb0365","first-page":"184","article-title":"ERK1\/2 in the brain mediates the effects of central resistin on reducing thermogenesis in brown adipose tissue","volume":"5","author":"Kosari","year":"2013","journal-title":"Int. J. Physiol. Pathophysiol. Pharmacol."},{"issue":"3","key":"10.1016\/j.vph.2025.107553_bb0370","doi-asserted-by":"crossref","first-page":"536","DOI":"10.2337\/db08-0822","article-title":"Hypothalamic ERK mediates the anorectic and thermogenic sympathetic effects of leptin","volume":"58","author":"Rahmouni","year":"2009","journal-title":"Diabetes"},{"issue":"9","key":"10.1016\/j.vph.2025.107553_bb0375","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0136768","article-title":"Corticotropin-releasing hormone receptor Type 1 (CRHR1) clustering with MAGUKs is mediated via its C-terminal PDZ binding Motif","volume":"10","author":"Bender","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.vph.2025.107553_bb0380","first-page":"36","article-title":"Characterization of Corticotropin-releasing Hormone Receptors (CRHRs) and Binding Proteins (CRHBPs) in Nile Tilapia: Molecular identification, functional analysis and tissue distribution","author":"Ji","year":"2024","journal-title":"Aquac. Rep."},{"issue":"10","key":"10.1016\/j.vph.2025.107553_bb0385","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1016\/j.jand.2014.07.005","article-title":"Diet or exercise interventions vs combined behavioral weight management programs: a systematic review and meta-analysis of direct comparisons","volume":"114","author":"Johns","year":"2014","journal-title":"J. Acad. Nutr. Diet."},{"issue":"2","key":"10.1016\/j.vph.2025.107553_bb0390","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1037\/amp0000517","article-title":"Lifestyle modification approaches for the treatment of obesity in adults","volume":"75","author":"Wadden","year":"2020","journal-title":"Am. Psychol."},{"issue":"12A","key":"10.1016\/j.vph.2025.107553_bb0395","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1017\/S1368980011002515","article-title":"Mediterranean diet pyramid today. Science and cultural updates","volume":"14","author":"Bach-Faig","year":"2011","journal-title":"Public Health Nutr."},{"key":"10.1016\/j.vph.2025.107553_bb0400","doi-asserted-by":"crossref","DOI":"10.1016\/j.exger.2023.112121","article-title":"Mediterranean diet in the management and prevention of obesity","volume":"174","author":"Dominguez","year":"2023","journal-title":"Exp. Gerontol."},{"issue":"9","key":"10.1016\/j.vph.2025.107553_bb0405","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph19094981","article-title":"The benefits of physical activity for people with obesity, independent of weight loss: a systematic Review","volume":"19","author":"Pojednic","year":"2022","journal-title":"Int. J. Environ. Res. Public Health"},{"issue":"9","key":"10.1016\/j.vph.2025.107553_bb0410","article-title":"Role of behavioral interventions in the Management of Obesity","volume":"13","author":"Olateju","year":"2021","journal-title":"Cureus"},{"issue":"11","key":"10.1016\/j.vph.2025.107553_bb0415","article-title":"Barriers and motivators to weight loss in people with obesity","volume":"15","author":"Binsaeed","year":"2023","journal-title":"Cureus"},{"issue":"5","key":"10.1016\/j.vph.2025.107553_bb0420","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1161\/HYP.0000000000000202","article-title":"Weight-loss strategies for prevention and treatment of hypertension: a scientific statement from the American Heart Association","volume":"78","author":"Hall","year":"2021","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.vph.2025.107553_bb0425","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1592\/phco.20.4.270.34882","article-title":"Orlistat, a new lipase inhibitor for the management of obesity","volume":"20","author":"Heck","year":"2000","journal-title":"Pharmacotherapy"},{"issue":"2","key":"10.1016\/j.vph.2025.107553_bb0430","doi-asserted-by":"crossref","first-page":"99","DOI":"10.4103\/2230-8210.81938","article-title":"Evaluation of efficacy and safety of orlistat in obese patients","volume":"15","author":"Jain","year":"2011","journal-title":"Indian J. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.vph.2025.107553_bb0435","doi-asserted-by":"crossref","first-page":"208","DOI":"10.5534\/wjmh.200010","article-title":"Anti-obesity drugs: long-term efficacy and safety: An updated Review","volume":"39","author":"Tak","year":"2021","journal-title":"World J. Mens Health"},{"issue":"12","key":"10.1016\/j.vph.2025.107553_bb0440","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1586\/erc.10.125","article-title":"Phentermine, topiramate and their combination for the treatment of adiposopathy (\u2019sick fat\u2019) and metabolic disease","volume":"8","author":"Bays","year":"2010","journal-title":"Expert Rev. Cardiovasc. Ther."},{"key":"10.1016\/j.vph.2025.107553_bb0445","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.101882","article-title":"Pharmacotherapy of obesity: an update on the available medications and drugs under investigation","volume":"58","author":"Chakhtoura","year":"2023","journal-title":"EClinicalMedicine"},{"issue":"5","key":"10.1016\/j.vph.2025.107553_bb0450","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/ijo.2013.145","article-title":"Effect of combined naltrexone and bupropion therapy on the brain\u2019s reactivity to food cues","volume":"38","author":"Wang","year":"2014","journal-title":"Int. J. Obes. (Lond)"},{"issue":"4","key":"10.1016\/j.vph.2025.107553_bb0455","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1111\/bcp.14210","article-title":"Naltrexone-bupropion (Mysimba) in management of obesity: a systematic review and meta-analysis of unpublished clinical study reports","volume":"86","author":"Onakpoya","year":"2020","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"3","key":"10.1016\/j.vph.2025.107553_bb0460","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/nrgastro.2016.170","article-title":"Bariatric surgery for obesity and metabolic disorders: state of the art","volume":"14","author":"Nguyen","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"19","key":"10.1016\/j.vph.2025.107553_bb0465","doi-asserted-by":"crossref","first-page":"4504","DOI":"10.12998\/wjcc.v11.i19.4504","article-title":"Long-term effectiveness, outcomes and complications of bariatric surgery","volume":"11","author":"Gulinac","year":"2023","journal-title":"World J. Clin. Cases"},{"issue":"2","key":"10.1016\/j.vph.2025.107553_bb0470","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1007\/s11695-015-1945-7","article-title":"Mechanism underlying the weight loss and complications of roux-en-Y gastric bypass","volume":"26","author":"Abdeen","year":"2016","journal-title":"Rev. Obes Surg."},{"issue":"6","key":"10.1016\/j.vph.2025.107553_bb0475","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1053\/j.gastro.2007.03.057","article-title":"Bariatric surgery: a review of procedures and outcomes","volume":"132","author":"Elder","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.vph.2025.107553_bb0640","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jpba.2014.06.012","article-title":"Related impurities in peptide medicines","volume":"101","author":"D'Hondt","year":"2014","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.vph.2025.107553_bb0480","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3410\/M4-19","article-title":"Quick fix or long-term cure? Pros and cons of bariatric surgery","volume":"4","author":"Madura","year":"2012","journal-title":"F1000 Med Rep"},{"issue":"2","key":"10.1016\/j.vph.2025.107553_bb0485","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2020.e03496","article-title":"The advantages and disadvantages of sleeve gastrectomy; clinical laboratory to bedside review","volume":"6","author":"Kheirvari","year":"2020","journal-title":"Heliyon"},{"issue":"10","key":"10.1016\/j.vph.2025.107553_bb0645","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2023.103714","article-title":"Immunogenicity risk assessment of synthetic peptide drugs and their impurities","volume":"28","author":"De Groot","year":"2023","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.vph.2025.107553_bb0650","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2023.101801","article-title":"Results from three phase 1 trials of NNC9204-1177, a glucagon\/GLP-1 receptor co-agonist: effects on weight loss and safety in adults with overweight or obesity","volume":"78","author":"Friedrichsen","year":"2023","journal-title":"Mol. Metab."},{"issue":"4","key":"10.1016\/j.vph.2025.107553_bb0490","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.soard.2009.05.011","article-title":"Systematic review of sleeve gastrectomy as staging and primary bariatric procedure","volume":"5","author":"Brethauer","year":"2009","journal-title":"Surg. Obes. Relat. Dis."},{"issue":"1","key":"10.1016\/j.vph.2025.107553_bb0495","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s11695-014-1385-9","article-title":"Laparoscopic sleeve gastrectomy versus laparoscopic Roux-en-Y gastric bypass for morbid obesity and related comorbidities: a meta-analysis of 21 studies","volume":"25","author":"Zhang","year":"2015","journal-title":"Obes. Surg."},{"issue":"2","key":"10.1016\/j.vph.2025.107553_bb0655","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/s42255-023-00966-w","article-title":"A GIPR antagonist conjugated to GLP-1 analogues promotes weight loss with improved metabolic parameters in preclinical and phase 1 settings","volume":"6","author":"Veniant","year":"2024","journal-title":"Nat. Metab."},{"issue":"11","key":"10.1016\/j.vph.2025.107553_bb0500","doi-asserted-by":"crossref","first-page":"464","DOI":"10.4239\/wjd.v8.i11.464","article-title":"Bariatric surgery and long-term nutritional issues","volume":"8","author":"Lupoli","year":"2017","journal-title":"World J. Diabetes"},{"issue":"9","key":"10.1016\/j.vph.2025.107553_bb0505","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1007\/s11695-011-0390-5","article-title":"A review of studies comparing three laparoscopic procedures in bariatric surgery: sleeve gastrectomy, Roux-en-Y gastric bypass and adjustable gastric banding","volume":"21","author":"Franco","year":"2011","journal-title":"Obes. Surg."},{"issue":"1","key":"10.1016\/j.vph.2025.107553_bb0510","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1093\/bmb\/ldw012","article-title":"The use of adjustable gastric bands for management of severe and complex obesity","volume":"118","author":"Hopkins","year":"2016","journal-title":"Br. Med. Bull."},{"issue":"10","key":"10.1016\/j.vph.2025.107553_bb0515","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1016\/j.numecd.2021.06.018","article-title":"Efficacy and effects of bariatric surgery in the treatment of obesity: network meta-analysis of randomized controlled trials","volume":"31","author":"Cosentino","year":"2021","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"issue":"6","key":"10.1016\/j.vph.2025.107553_bb0520","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1007\/s13300-020-00816-y","article-title":"Drug therapy in obesity: a Review of current and emerging treatments","volume":"11","author":"Williams","year":"2020","journal-title":"Diabetes Ther."},{"issue":"3","key":"10.1016\/j.vph.2025.107553_bb0525","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1056\/NEJMoa1512693","article-title":"Proopiomelanocortin deficiency treated with a Melanocortin-4 receptor agonist","volume":"375","author":"Kuhnen","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.vph.2025.107553_bb0530","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1056\/NEJMoa063988","article-title":"Clinical and molecular genetic spectrum of congenital deficiency of the leptin receptor","volume":"356","author":"Farooqi","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.vph.2025.107553_bb0535","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1172\/JCI200522081","article-title":"Leptin action in the forebrain regulates the hindbrain response to satiety signals","volume":"115","author":"Morton","year":"2005","journal-title":"J. Clin. Invest."},{"issue":"24","key":"10.1016\/j.vph.2025.107553_bb0540","doi-asserted-by":"crossref","first-page":"505","DOI":"10.21037\/atm.2017.11.10","article-title":"Semaglutide seems to be more effective the other GLP-1Ras","volume":"5","author":"Holst","year":"2017","journal-title":"Ann. Transl. Med."},{"issue":"2","key":"10.1016\/j.vph.2025.107553_bb0545","doi-asserted-by":"crossref","DOI":"10.3390\/ph17020199","article-title":"Glucagon-like Peptide-1 receptor agonists associated gastrointestinal adverse events: a cross-sectional analysis of the National Institutes of Health all of us cohort","volume":"17","author":"Aldhaleei","year":"2024","journal-title":"Pharmaceuticals (Basel)"},{"issue":"1","key":"10.1016\/j.vph.2025.107553_bb0550","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/s41392-024-01931-z","article-title":"Glucagon-like peptide-1 receptor: mechanisms and advances in therapy","volume":"9","author":"Zheng","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"issue":"2","key":"10.1016\/j.vph.2025.107553_bb0555","doi-asserted-by":"crossref","first-page":"490","DOI":"10.2337\/db12-0598","article-title":"Chronic treatment with a melanocortin-4 receptor agonist causes weight loss, reduces insulin resistance, and improves cardiovascular function in diet-induced obese rhesus macaques","volume":"62","author":"Kievit","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.vph.2025.107553_bb0560","doi-asserted-by":"crossref","DOI":"10.1016\/j.resp.2024.104370","article-title":"The MC4R agonist, setmelanotide, is associated with an improvement in hypercapnic chemosensitivity and weight loss in male mice","volume":"332","author":"Rivera","year":"2025","journal-title":"Respir. Physiol. Neurobiol."},{"issue":"4","key":"10.1016\/j.vph.2025.107553_bb0565","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1210\/jc.2014-4024","article-title":"RM-493, a melanocortin-4 receptor (MC4R) agonist, increases resting energy expenditure in obese individuals","volume":"100","author":"Chen","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.vph.2025.107553_bb0570","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/jcph.211","article-title":"Investigation of safety, tolerability, pharmacokinetics, and pharmacodynamics of single and multiple doses of a long-acting alpha-MSH analog in healthy overweight and obese subjects","volume":"54","author":"Royalty","year":"2014","journal-title":"J. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.vph.2025.107553_bb0575","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.cmet.2018.05.008","article-title":"Patients with obesity caused by Melanocortin-4 receptor mutations can be treated with a glucagon-like Peptide-1 receptor agonist","volume":"28","author":"Iepsen","year":"2018","journal-title":"Cell Metab."},{"issue":"9","key":"10.1016\/j.vph.2025.107553_bb0580","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.31982","article-title":"Weight loss outcomes associated with Semaglutide treatment for patients with overweight or obesity","volume":"5","author":"Ghusn","year":"2022","journal-title":"JAMA Netw. Open"},{"issue":"10","key":"10.1016\/j.vph.2025.107553_bb0585","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1038\/s41591-022-02026-4","article-title":"Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial","volume":"28","author":"Garvey","year":"2022","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.vph.2025.107553_bb0590","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1002\/oby.24222","article-title":"Safety profile of semaglutide versus placebo in the SELECT study: a randomized controlled trial","volume":"33","author":"Kushner","year":"2025","journal-title":"Obesity (Silver Spring)"},{"issue":"2","key":"10.1016\/j.vph.2025.107553_bb0595","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1001\/jama.2021.23619","article-title":"Effect of weekly subcutaneous Semaglutide vs daily Liraglutide on body weight in adults with overweight or obesity without diabetes: the STEP 8 randomized clinical trial","volume":"327","author":"Rubino","year":"2022","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.vph.2025.107553_bb0600","doi-asserted-by":"crossref","DOI":"10.1111\/ijpo.13061","article-title":"Evaluating potential predictors of weight loss response to liraglutide in adolescents with obesity: a post hoc analysis of the randomized, placebo-controlled SCALE teens trial","volume":"18","author":"Bensignor","year":"2023","journal-title":"Pediatr. Obes."},{"issue":"9","key":"10.1016\/j.vph.2025.107553_bb0605","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/jlcr.4023","article-title":"Peptides for trans-blood-brain barrier delivery","volume":"66","author":"Blades","year":"2023","journal-title":"J. Labelled Comp. Radiopharm."},{"issue":"16","key":"10.1016\/j.vph.2025.107553_bb0610","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.2174\/138161208784705423","article-title":"Blood-brain barrier and feeding: regulatory roles of saturable transport systems for ingestive peptides","volume":"14","author":"Kastin","year":"2008","journal-title":"Curr. Pharm. Des."},{"issue":"11","key":"10.1016\/j.vph.2025.107553_bb0615","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15112599","article-title":"Non-invasive drug delivery across the blood-brain barrier: a prospective analysis","volume":"15","author":"Niazi","year":"2023","journal-title":"Pharmaceutics"},{"issue":"11","key":"10.1016\/j.vph.2025.107553_bb0620","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14112533","article-title":"Instability challenges and stabilization strategies of pharmaceutical proteins","volume":"14","author":"Akbarian","year":"2022","journal-title":"Pharmaceutics"},{"issue":"10","key":"10.1016\/j.vph.2025.107553_bb0625","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/nchembio.1907","article-title":"A biomimetic approach for enhancing the in vivo half-life of peptides","volume":"11","author":"Penchala","year":"2015","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.vph.2025.107553_bb0630","first-page":"59","article-title":"Molecular pharmacology of glucagon-like peptide 1-based therapies in the Management of Type two Diabetes Mellitus and Obesity","volume":"14","author":"Alzahrani","year":"2025","journal-title":"Integr. Pharm. Res. Pract."},{"key":"10.1016\/j.vph.2025.107553_bb0635","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2023.117291","article-title":"Design, synthesis, and biological evaluation of a potential long-acting glucagon-like peptide-1 (GLP-1) analog","volume":"85","author":"Zhang","year":"2023","journal-title":"Bioorg. Med. Chem."},{"issue":"1","key":"10.1016\/j.vph.2025.107553_bb0660","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12933-023-01765-z","article-title":"Combination of exercise and GLP-1 receptor agonist treatment reduces severity of metabolic syndrome, abdominal obesity, and inflammation: a randomized controlled trial","volume":"22","author":"Sandsdal","year":"2023","journal-title":"Cardiovasc. Diabetol."},{"issue":"4","key":"10.1016\/j.vph.2025.107553_bb0665","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1007\/s11695-023-06484-8","article-title":"Efficacy of the glucagon-like Peptide-1 receptor agonists Liraglutide and Semaglutide for the treatment of weight regain after bariatric surgery: a retrospective observational study","volume":"33","author":"Jensen","year":"2023","journal-title":"Obes. Surg."}],"container-title":["Vascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189125000928?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189125000928?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T20:02:59Z","timestamp":1781208179000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1537189125000928"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":134,"alternative-id":["S1537189125000928"],"URL":"https:\/\/doi.org\/10.1016\/j.vph.2025.107553","relation":{},"ISSN":["1537-1891"],"issn-type":[{"value":"1537-1891","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hypothalamic regulation of obesity: Revealing the therapeutic potential of a novel anti-obesity peptide","name":"articletitle","label":"Article Title"},{"value":"Vascular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vph.2025.107553","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"107553"}}